Salk scientists find brain’s immune cells form some plaques as a defense in Alzheimer’s, suggesting a new therapeutic direction One of the characteristic hallmarks of Alzheimer’s disease (AD) is the buildup of amyloid-beta plaques in the brain. Most therapies designed to treat AD target these plaques, but they’ve largely failed in clinical trials. New research by Salk...
